Ruslan Medzhitov

Ruslan Medzhitov

Auto-generated profile, based on publicly available information

Ruslan Medzhitov

Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
RMRuslan Medzhitov
Ruslan Medzhitov

3 August 2000 in New England Journal of Medicine
Verified
Journal Article
Closed access
RMRuslan Medzhitov
Ruslan Medzhitov
CJCharles Janeway
Charles Janeway
The immune system has traditionally been divided into innate and adaptive components, each with a different function and role. The adaptive component is organized around two classes of specialized cells, T cells and B cells. Since each lymphocyte displays a single kind of structurally unique receptor, the repertoire of antigen receptors in the entire population of lymphocytes is very large and extremely diverse. The size and diversity of this repertoire increase the probability that an individual lymphocyte will encounter an antigen that binds to its receptor, thereby triggering activation and proliferation of the cell. This process, termed clonal selection, accounts . . .

28 February 2000 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
RMRuslan Medzhitov
Ruslan Medzhitov
CJCharleS. Jr Janeway
CharleS. Jr Janeway

1 October 2000 in Trends in Microbiology
Verified
Journal Article
Closed access
RMRuslan Medzhitov
Ruslan Medzhitov
JJJr Charles Janeway
Jr Charles Janeway

4 March 2002 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAlbert Bendelac
Albert Bendelac
RMRuslan Medzhitov
Ruslan Medzhitov
Since Jules Freund reported that crude mycobacterial extracts greatly promoted immune responses to antigens ([1][1]), the use of adjuvants has become a widespread, but poorly understood practice to promote T and B cell responses ([2][2]). Recent studies have begun to identify the chemical nature of